Discussant - Diagnosis of heart failure: natriuretic peptides and novel methods

29 August 2025 (07:00 - 18:00)

Organised by:

8 More presentations in this session

Presentation thumbnail

Clinical correlates and outcomes associated with B-type natriuretic peptide changes and their interaction with eplerenone in acute heart failure: findings from the EARLEIR trial

Doctor A. Tezuka (Tokyo, JP)

Presentation thumbnail

Prognosis and NT-proBNP decrease in heart failure patients from admission to follow up

Ms P. Rodriguez Montes (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

The prognostic implications of serum NT-pro B-type Natriuretic Peptide (NT-proBNP) in emergency medical admissions.

Doctor M. Mckittrick (Limerick, IE)

Abstract Slides Video

Presentation thumbnail

Artificial intelligence-assisted point-of-care lung ultrasound to compare B-lines and congestion scores with NTproBNP levels prior to discharge patients with acute heart failure stage C

Doctor C. Neerapattanakul (Bangkok, TH)

Abstract Slides

Presentation thumbnail

The responses of B-type natriuretic peptide (BNP), mature BNP, proBNP, atrial natriuretic peptide, and N-terminal proBNP to sacubitril/valsartan differs between responders and non-responders

Doctor T. Nishikimi (Osaka, JP)

Abstract Slides Video

Access the full session

Session thumbnail

New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

All you need to know about diagnosing heart failure in adult congenital heart disease

Congress Presentation

Heart failure

Congress Session

Which device might help your HFpEF patient?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources